Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 282 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
The DNA-PK Inhibitor AZD7648 Alone or Combined with Pegylated Liposomal Doxorubicin in Patients with Advanced Cancer: Results of a First-in-human Phase I/IIa Study
Timothy A Yap,Patricia LoRusso, Rowan E Miller,Rebecca Kristeleit,Amanda G Paulovich, Stephen McMorn, Lenka Oplustil O'Connor,Benedetta Lombardi, Paola Marco-Casanova, Eric T Gangl, Bharat Patel,Mark J O'Connor,Emma Dean, Roman Zviezdin,Ruth Plummer
British journal of cancer (2025)
Cited0Views0WOSBibtex
0
0
Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination-Deficient Breast Cancer
Flaminia Pedretti, Mohmed Abdalfttah, Benedetta Pellegrino,Francesca Mateo, Paula Martínez-Sanz, Andrea Herencia-Ropero, Andreu Òdena, Pau Clavell-Revelles, Giorgia Casali, Heura Domènech, Laia Monserrat, Dražen Papić, Alba Mas Malavila, Anna Pascual-Reguant, Herena Eixarch,Marta Guzmán, Olga Rodríguez, Judit Grueso,Sara Simonetti, Roberta Fasani,Paolo Nuciforo, Carmen Espejo, Stefan Florian,Miguel Ángel Pujana, Lara Nonell,Joan Seoane,Viia Valge-Archer,Mark J O'Connor, Juan C Nieto,Holger Heyn,Judith Balmaña,Alba Llop-Guevara,Violeta Serra
Cancer researchno. 10 (2025): 1888-1908
Cited0Views0WOSBibtex
0
0
ADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib (AZD1775) As Treatment for Recurrent or Persistent Uterine Serous Carcinoma
Joyce F Liu,Nicoletta Colombo, Amit M Oza,Jean-Sebastien Frenel,Bradley R Corr, Maria M Rubinstein, Nicole S Nevadunsky,Stephanie Lheureux, Lydia Gaba, Lucía González Cortijo,Vanda Salutari,Benoit You,Sarah Chiang,Mark J O'Connor, Lenka Oplustil O'Connor,Didier Meulendijks, Mahmuda Khatun,Dana Ghiorghiu,Ana Oaknin
Journal of clinical oncology official journal of the American Society of Clinical Oncologypp.JCO2401606-JCO2401606, (2025)
Cited0Views0WOSBibtex
0
0
Neoadjuvant PARP Inhibitor Scheduling in BRCA1 and BRCA2 Related Breast Cancer: PARTNER, a Randomized Phase II/III Trial
Jean E Abraham, Lenka Oplustil O'Connor, Louise Grybowicz,Karen Pinilla Alba,Alimu Dayimu,Nikolaos Demiris,Caron Harvey, Lynsey M Drewett, Rebecca Lucey, Alexander Fulton, Anne N Roberts, Joanna R Worley, Ms Anita Chhabra,Wendi Qian, Jessica Brown,Richard Hardy,Anne-Laure Vallier, Steve Chan, Maria Esther Una Cidon, Elizabeth Sherwin, Amitabha Chakrabarti, Claire Sadler, Jen Barnes, Mojca Persic, Sarah Smith, Sanjay Raj, Annabel Borley, Jeremy P Braybrooke, Emma Staples, Lucy C Scott, Cheryl A Palmer, Margaret Moody, Mark J Churn,Domenic Pilger, Guido Zagnoli-Vieira,Paul W G Wijnhoven, Mukesh B Mukesh, Rebecca R Roylance,Philip C Schouten, Nicola C Levitt,Karen McAdam, Anne C Armstrong, Ellen R Copson,Emma McMurtry, Susan Galbraith,Marc Tischkowitz,Elena Provenzano,Mark J O'Connor, Helena M Earl, PARTNER Trial Group
Nature communicationsno. 1 (2025): 4269-4269
Cited0Views0WOSBibtex
0
0
Corrigendum to “cell Cycle Dysregulation in Cancer” [pharmacological Reviews 77 (2025) 100030]
Antonino Glaviano, Samarendra K. Singh, E. Hui Clarissa Lee, Elena Okina, Hiu Yan Lam, Daniela Carbone,E. Premkumar Reddy,Mark J. O’Connor,Andrew Koff,Garima Singh,Justin Stebbing,Gautam Sethi, Karen Carmelina Crasta,Patrizia Diana,Khandan Keyomarsi,Michael B. Yaffe,Seth A. Wander,Aditya Bardia,Alan Prem Kumar
Pharmacological Reviewsno. 3 (2025)
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 284

#Citation: 20014

H-Index: 60

G-Index: 141

Sociability: 7

Diversity: 3

Activity: 64

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn